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Background: Lyme borreliosis, caused by tick-borne Borrelia burgdorferi, is a multi-phasic, multi-system disease in
humans. Similar to humans, C3H mice develop arthritis and carditis, with resolution and periodic bouts of
recurrence over the course of persistent infection. Borrelia burgdorferi arthritis-related protein (Arp/BBF01), a highly
conserved protein among B. burgdorferi s.s. isolates, has been shown to be antigenic in humans with Lyme
borreliosis, and a target for antibody-mediated disease resolution in the mouse model.
Results: A mutant strain of B. burgdorferi s.s. deficient of the arp gene and a complemented version of that mutant
were created and examined for phenotypic effects in mice compared to wild-type B. burgdorferi. Deletion of arp did
not abolish infectivity, but did result in a higher infectious dose compared to wild-type B. burgdorferi, which was
restored by complementation. Spirochete burdens in tissues of C3H-scid mice were lower when infected with the
arp mutant, compared to wild-type, but arthritis was equally severe. Spirochete burdens were also lower in C3H
mice infected with the arp mutant, but disease was markedly reduced. Ticks that fed upon infected C3H mice were
able to acquire infection with both wild-type and arp mutant spirochetes. Arp mutant spirochetes were marginally
able to be transmitted to naïve hosts by infected ticks.
Conclusion: These results indicated that deletion of BBF01/arp did not abrogate, but diminished infectivity and
limited spirochete burdens in tissues of both immunocompetent and immunodeficient hosts, and attenuated, but
did not abolish the ability of ticks to acquire or transmit infection.
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Lyme disease, caused by tick-borne Borrelia burgdorferi,
is a multi-systemic and multi-phasic disease in humans,
which includes pauciarticular arthritis in up to 60% of
untreated patients [1,2]. In the absence of antibiotic
treatment, arthritis and other lesions undergo resolution
with variable bouts of recurrence over the course of
months to years of persistent infection [3]. Laboratory
mice develop arthritis and carditis that follow a similar
multi-phasic course as humans, with resolution and
periodic bouts of recurrence over the course of persis-
tent infection [4]. The mouse model has implicated the
humoral immune response as a critical factor in arthritis
and carditis resolution. Infection of T-cell deficient (Tcr
α/βnull, Tcr γ/δ-null), but not B-cell deficient (Igh6-null)
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reproduction in any medium, provided the ornull mice follows a course of resolution that is similar to
fully immunocompetent mice [5], and passive transfer of
serum from actively infected immunocompetent mice
that have undergone disease resolution (immune serum)
into infected SCID mice results in complete resolution
of arthritis and carditis, but not clearance of infection
[6-8].
Identification of the B. burgdorferi antigens targeted by
antibodies that mediate disease resolution is complicated
by the fact that B. burgdorferi grown in culture medium
does not reflect the antigenic profile of spirochetes dur-
ing mammalian infection [9,10]. As a means to identify
vulnerable antigenic targets that are expressed in the
mammalian host that are responsible for antibody-
mediated disease resolution, immune serum from ac-
tively infected mice has been used to probe B.
burgdorferi genomic expression libraries or outer mem-
brane extracts. These efforts revealed arthritis-related
protein (BBF01/Arp) as well as decorin binding protein. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Dose-related infectivity of arp null (Δarp3),
Δarp3-complemented (Δarp3 + lp28-1G) and wild-type B.
burgdorferi in infant ICR mice, based upon culture of sub-
inoculation site and urinary bladder at 2 weeks after
inoculation
Inoculum dose Δarp3 Δarp3 + lp28-1G wild-type
101 0/4* 0/4 0/4
102 0/4 0/4 0/4
103 0/4 0/4 0/4
104 1/4 4/4 4/4
105 2/4 4/4 4/4
* number of positive mice/number of mice tested.
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tion [8,11-13]. Antiserum generated in mice hyper-
immunized with non-lipidated recombinant Arp or
DbpA induced arthritis and carditis resolution, but did
not eliminate infection, when passively transferred to ac-
tively infected SCID mice [8,12]. Immunization with
DbpA was found to induce protective immunity against
cultured spirochetes [11,14], but not tick-borne spiro-
chetes [15], whereas Arp immunization was ineffective
at eliciting protective immunity against cultured spiro-
chetes [16]. Outer surface protein C (OspC), another im-
munogenic protein expressed during infection, has also
been shown to be vulnerable to passively transferred
OspC antibody in SCID mice, but is down-regulated in
response to specific antibody, thereby avoiding immune
clearance in immunocompetent mice [17,18].
Based upon the presence of a leader sequence, arp en-
codes a putative lipoprotein that is expressed in ticks
and throughout the course of mammalian infection and
has been shown to stimulate the production of antibody
in both experimentally infected mice and naturally
infected humans [13,16,19-21]. Genomic comparison
among several B. burgdorferi sensu stricto (s.s.) strains
reveals highly conserved BBF01/arp sequences (95-100%
identity from GenBank Blast). Curiously, the genomes of
other B. burgdorferi sensu lato strains that are available
in GenBank, such as B. afzelii and B. garinii, do not ap-
pear to have an arp homolog. In contrast to arp conser-
vation in B. burgdorferi s.s. strains, dbpA and ospC,
which also encode immunogenic antigens that are
expressed during infection [19,21-23], have considerable
variation (81-85% identity) among the same B.
burgdorferi s.s. strains (GenBank). As noted, both Arp
and DbpA stimulate an arthritis-resolving immune re-
sponse [8], and DbpA and OspC elicit protective im-
mune responses against challenge [11,14,24]. It is
therefore curious that Arp has such a conserved se-
quence among B. burgdorferi s.s. strains, when it is so
obviously subjected to immune selection pressure. The
present study explored the biological behavior of B.
burgdorferi devoid of, or complemented with, Arp. Arp
was found to be non-essential for infectivity, but it
influenced infectious dose, spirochete burdens in tissues,
arthritis severity, and tick infection kinetics, underscor-
ing its biological significance.
Results
Seven B. burgdorferi B31-arp deletion mutants (Δarp)
were created, and found to grow equally well in BSKII
medium as B31 (wild-type) spirochetes. The 7 Δarp mu-
tants were initially tested for infectivity in infant ICR
mice, which serve as an inexpensive system for titrating
infectivity [5]. All seven mutants were determined to be
flagellin B (flaB) DNA-positive and arp DNA-negativeby polymerase chain reaction (PCR), following growth
selection in streptomycin. Four 2-day-old mice were in-
oculated with 106 of each Δarp mutant or wild-type spi-
rochetes, and sub-inoculation site and urinary bladder
were cultured to determine infectivity and ability to dis-
seminate at 7 and 21 days after inoculation. All were in-
fectious, and all disseminated to the urinary bladder.
Spirochetes cultured from the inoculation site and urin-
ary bladder were tested by PCR for presence of flaB and
arp. Urinary bladder isolates from mice that were flaB-
positive and arp-negative were selected for further ana-
lysis and confirmed to be arp-null. Upon subsequent in-
oculation of infant ICR mice with wild-type or each of
the seven Δarp mutants, arthritis was of equivalent se-
verity as mice infected with B31 among all groups of
mice, indicating that B. burgdorferi devoid of arp were
not only infectious, but also equally pathogenic as wild-
type B. burgdorferi in susceptible infant mice. One arp
isolate (Δarp3) was selected for further analysis.
The median infectious dose (ID50) of Δarp3 was com-
pared to wild-type and to Δarp3 complemented with the
plasmid lp28-1G containing arp (Δarp3 + lp28-1G).
Groups of 4 infant ICR mice were inoculated subder-
mally with 101, 102, 103, 104, or 105 spirochetes. Mice
were necropsied at 2 weeks, and sub-inoculation site
and urinary bladder were cultured (Table 1). The ID50 of
wild-type was 5×103 spirochetes, whereas the ID50 of
Δarp3 was 8×104 spirochetes. Relative infectivity could
be restored by complementation of the Δarp3 mutant
with lp28-1G, resulting in an ID50 identical to wild-type.
Subsequent experiments in C3H and C3H-scid mice
therefore used an infectious dose of 105 or greater
spirochetes.
Four C3H-scid mice were each inoculated with 106
wild-type and five C3H-scid mice were each inoculated
with 106 Δarp3 spirochetes, and then necropsied at 60
days of infection to compare the full range of pathoge-
nicity of each inoculum, unencumbered by acquired
immunity. All inoculation sites and urinary bladders
were culture-positive in both groups. Spirochetes were
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whereas only 2/4 (one sample not collected) Δarp3 ino-
culated mice were bacteremic. All mice in both groups
had severe (mean arthritis score 3.0 ± 0 SD) arthritis in
tibiotarsal joints, as well as arthritis in both knees, and
all mice had carditis. Despite equally severe disease,
spirochete burdens in sub-inoculation, heart base, and
tibiotarsal tissues, based upon flaB quantitative PCR (Q-
PCR), were significantly lower (P ≤ 0.05) in Δarp3
infected C3H-scid mice compared to wild-type infected
mice (Figure 1). Spirochete burdens were also lower in
ventricular muscle and quadriceps muscle, but differ-
ences were not statistically significant.
A confirmatory experiment was performed in which 5
C3H-scid mice were each inoculated with 106 wild-type
and 5 C3H-scid mice were each inoculated with 106
Δarp3 spirochetes, and necropsied on day 28 after in-
oculation. Inoculation sites and urinary bladders in all
mice from both groups were culture-positive, and all
mice in both groups were bacteremic. Arthritis severity
scores were equivalent in both groups (mean 2.8 ± 0.4
SD wild-type vs. mean 2.4 ± 0.5 SD Δarp3). Significantly
lower flaB Q-PCR spirochete burdens (P ≤ 0.05) were
found in tissues of Δarp3 infected C3H-scid mice com-
pared to wild-type infected C3H-scid mice, including in-
oculation site (320 ± 486 SD vs 249,660 ± 187,097 SD),
heart base (983 ± 1,353 SD vs 514,400 ± 171,404 SD),
ventricular muscle (9,656 ± 5,911 SD vs 432,260 ±
374,173 SD), and tibiotarsus (201 ± 187 SD vs 163,520 ±
89,127 SD). Spirochete burdens were also reduced in
quadriceps muscle (3,730 ± 1,412 SD vs 58,640 ± 74,839
SD), but differences were not statistically significant
(P = 0.07).Figure 1 Borrelia burgdorferi flaB DNA copies per mg tissue
weight (means ± standard deviations) in subinoculation site
(subIN), heart base (HB), ventricular muscle (VM), quadriceps
muscle (Quad) and tibiotarsus (Tibio) from 4 C3H-scid mice
inoculated with wild-type (white bars) compared to 5 C3H-scid
mice inoculated with arp null Δarp3 B. burgdorferi (black bars).
(*, P ≤ 0.05).Next, groups of 5 immunocompetent C3H mice were
inoculated with 105 wild-type or Δarp3 spirochetes, and
then necropsied on days 14, 28 and 42. Tissues were
examined for arthritis and carditis, and flaB Q-PCR was
performed on sub-inoculation site, heart base, ventricular
muscle, tibiotarsus and quadriceps muscle. Inoculation
sites of all mice were culture-positive at each interval
tested, but none of the urinary bladders of mice inocu-
lated with Δarp3 were culture-positive at 14 days,
suggesting delayed dissemination, or reduced sensitivity
due to lower tissue burdens (Table 2). Compared to in-
oculation site, urinary bladders were less consistently
culture-positive in both groups of mice, underscoring the
greater accuracy of PCR for assessing dissemination and
tissue burdens (Table 3). At 14 days, 1/5 wild-type inocu-
lated mice had 1+ inflammation of the tibiotarsus and 5/
5 had carditis, whereas none of the Δarp3 inoculated
mice had inflammatory lesions in joints or heart at this
interval. At 28 days, 5/5 wild-type inoculated mice had
both arthritis (1.6 ± 0.5 SD severity) and carditis, whereas
only 1/5 Δarp3 inoculated mice had carditis and none
had arthritis. At 42 days, 3/3 wild-type inoculated mice
continued to have arthritis (1.5 ± 0.5 SD) and carditis,
and 1/5 Δarp3 mice had arthritis (1+ severity) and 2/5
had carditis. PCR-positive tissue samples at all intervals
indicated that wild-type infected mice had higher spiro-
chete burdens in tissues compared to Δarp3 infected
mice (Figure 2). At day 14, most tissues from wild-type
inoculated mice were PCR-positive, whereas very few tis-
sues from Δarp3 inoculated mice were PCR-positive
(Table 3). The rate of PCR-positive tissues increased in
the Δarp3 inoculated mice on days 28 and 42 to rates
similar to wild-type infected mice, but flaB DNA copy
numbers were consistently lower.
A confirmatory experiment was performed in which
groups of 4 C3H mice were inoculated with 106 wild-
type or Δarp3 spirochetes, and then necropsied on day
28 to verify the difference in tissue spirochete burdens
in heart base, ventricular muscle, quadriceps muscle,
and tibiotarsal tissue. Tissues were not collected for
histopathology. In wild-type infected mice, 4/4 inocula-
tion sites and 3/4 urinary bladders were culture-positive,
and 3/3 inoculation sites (one sample contaminated) and
0/4 urinary bladders were culture-positive in Δarp3
infected mice. Spirochete burdens were significantly
lower (P ≤ 0.05) in tissues of Δarp3 infected mice com-
pared to wild-type infected mice, including sub-
inoculation site (139 ± 266 SD vs. 1,761 ± 1,682 SD),
heart base (45 ± 54 SD vs. 2,333 ± 1,400 SD), ventricular
muscle (28 ± 26 SD vs 448 ± 276 SD), and quadriceps
muscle (15 ± 23 SD vs 367 + 291 SD). Spirochete bur-
dens were also lower in tibiotarsus tissue of Δarp3
infected mice (13 ± 11 SD vs 16,171 ± 29,765 SD), but
differences were not statistically different (P = 0.16).
Table 2 Outcome of infection of C3H mice with wild-type vs. arp null (Δarp3) Borrelia burgdorferi at intervals (days)
after inoculation
Culture Inflammation
Day Inoculum Inoc. site Urinary bladder Tibiotarsus Knee Heart
14 wild-type 5/5* 3/5 1/5 0/5 5/5
Δarp3 5/5 0/5 0/5 0/5 0/5
28 wild-type 5/5 4/5 5/5 4/5 5/5
Δarp3 5/5 2/4** 0/5 0/5 1/5
42 wild-type 3/3 2/3 3/3 0/3 1/3
Δarp3 4/4** 5/5 1/5 0/5 2/5
* number positive/number tested.
** one culture sample contaminated.
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both C3H-scid mice as well as C3H mice infected with
Δarp3 had lower spirochete burdens in tissues.
Sera from C3H mice that were confirmed to be
culture-positive at 60 days of infection with wild-type or
Δarp3 spirochetes were determined to be appropriately
sero-reactive against recombinant Arp antigen (Arp
seropositive or seronegative, respectively). Serum anti-
body titers from Δarp3 infected mice were equivalent to
antibody titers in mice infected with wild-type infected
mice when tested against B. burgdorferi lysate antigen
(≥1:24,300), and antibody titers to recombinant Arp
antigen were verified to be either negative (Δarp3) or
positive (Δarp3 + lp28-1G), with titers equivalent to Arp
titers in wild-type immune sera (1:2,700).
Larval ticks were fed upon the before-mentioned wild-
type or Δarp3 infected C3H mice 3 days before necropsy
at day 42. Replete ticks were allowed to molt and harden
into nymphs, and then tested by Q-PCR for flaB and
arp DNA. Among ticks that fed upon wild-type infected
mice, 30/30 were PCR positive for both flaB and arp,
with 53,950 mean ± 84,668 SD flaB copy numbers per
tick. In contrast, 40/50 ticks that fed upon Δarp3
infected mice were flaB-positive, with significantly lower
spirochete loads per positive tick (1,384 mean ± 1,780Table 3 Rate of PCR (flaB DNA) positivity of sub-
inoculation site, heart base, ventricular muscle,
quadriceps muscle and tibiotarsus tissue from C3H mice
at intervals (days) after inoculation with wild-type vs. arp
null (Δarp3) Borrelia burgdorferi
Day Inoculum SubIN Hrt base Vent M Quad M Tibiotarsus
14 wild-type 4/5* 5/5 5/5 4/5 4/5
Δarp3 2/5 1/5 0/5 0/5 0/5
28 wild-type 5/5 ND** 5/5 5/5 4/5
Δarp3 4/5 ND 3/5 3/5 5/5
42 wild-type 3/3 3/3 3/3 3/3 3/3
Δarp3 3/5 5/5 4/5 3/5 2/5
* number positive/number tested.
** ND = not done.SD flaB copy numbers, P = 0.0002). Tick cohorts from
individual Δarp3 infected mice contained 9/10, 5/10, 10/
10, 6/10 and 10/10 positive ticks. Results demonstrated
that Δarp3 can be acquired by ticks from infected C3H
mice, but ticks that acquired Δarp3 harbored fewer
organisms compared to wild-type.
The ability of Δarp3 spirochetes to be transmitted
from infected ticks to naïve C3H mice was next evalu-
ated by placing 10 nymphal ticks from the wild-type and
Δarp3 positive tick cohorts (above) onto each recipient
mouse. Mice were necropsied at 3 weeks following tick
feeding, and ear, heart base, ventricular muscle, tibiotar-
sus and quadriceps muscle were tested by flaB Q-PCR.
Among 5 mice fed upon by ticks carrying wild-type spi-
rochetes, 4/5 mice became infected, and all tissue sites
from the 4 positive mice were PCR-positive, with high
copy numbers of flaB DNA in tissues (Figure 3). In con-
trast, 2 of the 7 mice that were fed upon by Δarp3
infected ticks were positive, but only a single tissue in
each of the positive mice contained low copy numbers
of flaB DNA. Results indicated that Δarp3 spirochetes
are capable of tick-borne transmission. Since ticks
infected with Δarp3 spirochetes had significantly fewer
spirochete loads compared to ticks infected with wild-
type spirochetes, it could not be concluded that there
was less efficient transmission.
Discussion
This study examined the effect of targeted deletion of
BBF01/arp on infectivity of B. burgdorferi B31. The me-
dian infectious dose of B. burgdorferi B31 with an arp
null mutation was elevated approximately ten-fold com-
pared to wild-type spirochetes, and restored by comple-
mentation. Therefore, it is apparent that BBF01/arp is
not essential for infectivity of the mammalian host. This
is supported by indirect results of others, who demon-
strated diminished infectivity in B. burgdorferi spiro-
chetes lacking linear plasmid 28–1 (lp28-1), which
encodes only two unique and functional genes, vlsE and
arp [25-29]. Furthermore, clones of B. burgdorferi B31
Figure 2 Borrelia burgdorferi flaB DNA copies per mg tissue
weight (means ± standard deviations) in PCR-positive tissues
summarized in Tables 2 and 3, including sub-inoculation site
(subIN), heart base (HB), ventricular muscle (VM), quadriceps
muscle (Quad) and tibiotarsus (Tibio) from C3H mice inoculated
with wild-type (white bars) compared to arp null Δarp3 B.
burgdorferi (black bars) at day 14 (a), day 28 (b) and day 42 (c)
of infection. (*, P ≤ 0.05) ND: not determined.
Figure 3 Borrelia burgdorferi flaB DNA copies per mg tissue
weight (means ± standard deviations) in PCR-positive tissues,
including ear, heart base (HB), ventricular muscle (VM),
quadriceps muscle (QM) and tibiotarsus (Tt) of mice at 3 weeks
after feeding of nymphal ticks from tick cohorts infected with
wild-type or arp null Δarp3 B. burgdoferi.
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arp, remained infectious and capable of persistence,
similar to wild-type spirochetes [25].
Examination of the pathogenicity of various B.
burgdorferi B31 clones lacking lp28-1 has shown that
clones lacking lp28-1 were infectious in BALB/c-scidmice and reached similar tissue burdens as wild-type
spirochetes, but were incapable of inducing arthritis
[29]. Results of the current study indicate that infection
of C3H-scid mice with arp null spirochetes resulted in
lower spirochete burdens in tissues with development of
equally severe arthritis as that induced by wild-type spi-
rochetes. Thus, it appears that arp null spirochetes are
equally (if not more) arthritogenic than wild-type B.
burgdorferi in C3H-scid mice. The lack of effect on tis-
sue burdens and arthritis in BALB/c-scid mice infected
with B. burgdorferi devoid of the entire lp28-1 plasmid,
but reduced burdens in infections with arp null spiro-
chetes observed in the current study are likely due to
the experimental variations in B. burgdorferi strains
(B31-5A11 vs. B31-A3), mouse strains (BALB/c-scid vs.
C3H-scid), or a number of other possible genetic
variables.
Lack of lp28-1 has been associated with failure to per-
sist in immunocompetent mice. This has been attributed
to vlsE, since clones lacking a region of the plasmid that
encodes arp are capable of persistent infection [25,29].
The current study examined persistence in immuno-
competent C3H mice up to 42 days after inoculation,
and demonstrated that arp null spirochetes were indeed
capable of persistence. In the present study, we also
infected mice for antibody evaluation at 60 days of
culture-confirmed infection, and thus verified persis-
tence for up to 60 days. As in C3H-scid mice, arp null
spirochete burdens were lower in C3H mouse tissues
compared to wild-type spirochetes. Notably, arthritis se-
verity was markedly reduced in C3H mice infected with
arp null spirochetes. Since arp null spirochetes are fully
arthritogenic in SCID mice, these results suggest that
the lower pathogenicity of arp null spirochetes in im-
munocompetent mice is a consequence of susceptibility
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gens that are expressed during infection have also been
shown to be susceptible to arthritis-resolving antibody
responses, including DbpA [8], BmpA, and BmpB [30].
In the absence of Arp, these or other antigens may be
targets of immune-mediated phenotypic effects noted in
the present study.
Although arp null spirochetes are capable of surviving
in the murine host, their ability to do so appears to be
compromised, since arp null spirochete burdens were 2
logs fewer in tissues of SCID mice compared to wild
type spirochetes, and were even lower in immunocom-
petent mice. Thus, arp null spirochetes appear to be ei-
ther less fit to grow or are more vulnerable to innate
and acquired immune factors compared to wild type spi-
rochetes. This lack of fitness is likely responsible for the
additional phenotypic effect of arp deletion that was ob-
served in acquisition and transmission by vector ticks.
Larval ticks were fed upon mice infected with wild-type
or arp null spirochetes, and allowed to molt into
nymphs. Ticks became infected with both types of spiro-
chetes, but following molting, nymphal ticks that were
colonized with arp null spirochetes had significantly
lower spirochete loads per tick compared to ticks colo-
nized with wild type spirochetes. The lower arp null
spirochete loads were likely influenced by the lower
spirochete burdens in tissues of mice that were fed upon
by the ticks. This effect has been demonstrated by others
[31] in which ticks that fed upon MyD88 deficient mice
infected with B. burgdorferi had higher spirochete bur-
dens compared to ticks that fed upon wild-type mice.
MyD88 deficient mice have significantly higher spiro-
chete tissue burdens compared to wild-type mice. The
lower rate of transmission of arp null spirochetes from
infected nymphal ticks to naïve mice could also have
been influenced lower spirochete burdens in arp null
colonized ticks. Further studies are needed to examine
dynamics within ticks, but there is normally a significant
burst of replication of spirochetes within fed ticks [32]
that did not appear to occur in ticks colonized with arp
null spirochetes. Nevertheless, results indicated that arp
null spirochetes could be acquired and transmitted by
vector ticks, albeit at diminished levels.
Conclusion
Deletion of the arp gene resulted in a modest pheno-
typic effect, including reduced infectious dose, reduced
fitness of B. burgdorferi for growth in the mammalian
host, and reduced ability for acquisition and transmis-
sion by the vector tick. Deletion of a number of B.
burgdorferi genes has been found to have only mild
phenotypic effects upon infectivity and persistence of B.
burgdorferi (reviewed in [33]). This is likely due in large
part to compensatory up-regulation of other genes.Although the function of Arp remains unknown, the
current study in which arp was deleted with relatively
modest phenotypic effects underscores the complexity of
B. burgdorferi biology and emphasizes caution in attri-




Specific-pathogen-free, 3 to 5 week old C3H/HeN (C3H)
and severe combined immunodeficient (SCID) C3H/
Smn.CIcrHsd-Prkdcscid (C3H-scid) mice were obtained
from Frederick Cancer Research Center (Frederick, MD)
and Harlan Sprague Dawley, Inc. (Indianapolis, IN),
respectively. Pregnant Swiss outbred Crl:CD1(ICR) mice
were obtained from Charles River Laboratories
(Hollister, CA). Mice were infected by subdermal inocu-
lation of mid-log phase B. burgdorferi in 0.1 ml culture
medium on the dorsal thoracic midline. Mice were killed
by carbon dioxide narcosis and exsanguination by
cardiocentesis. Infection status of mice was confirmed at
necropsy by culture of the urinary bladder and sub-
inoculation site, as described [4]. Animal use was ap-
proved by the University of California Davis Animal
Care and Use Committee. University of California Davis
has a Public Health Service Animal Welfare Assurance
on file and is fully accredited by the Association for the
Assessment and Accreditation of Laboratory Animal
Care International.
Histopathology
Joint (knee and tibiotarsus) and heart tissues were fixed
in neutral buffered formalin, demineralized, paraffin-
embedded, sectioned, and stained with hematoxylin and
eosin. Tissues were blindly evaluated and tibiotarsal
arthritis severity was scored on a scale of 0 (negative), 1
(mild), 2 (moderate) or 3 (severe). Based upon extensive
use of this scoring system, a score of 3 is generally lim-
ited to SCID mice, and a score of 1–2 is typical of im-
munocompetent C3H mice [4,34,35]. The prevalence of
carditis was also blindly recorded, but a severity score is
not possible with carditis, due to variation in severity
among mice within a particular treatment group, thereby
precluding accurate scoring [34].
Bacterial strains
Low passage infectious B. burgdorferi s.s. strain B31-A3
(wild-type) was acquired from D. Scott Samuels, Univer-
sity of Montana, and utilized as both a wild-type control
and for genetic manipulation. B31-A3 is a clonal isolate
of B31 MI, the prototype B31 strain utilized for genome
sequencing [36,37]. An additional B31-A3 variant, B.
burgdorferi B31-A3-lp28-1-G, containing a gentamicin
resistance gene on lp28-1 [38], was provided by D. Scott
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boratories). Spirochetes were grown in modified Barbour
Stoenner Kelly (BSKII) medium [39] with 6% rabbit
serum. Inocula were enumerated by dark-field micros-
copy using a Petroff-Hausser chamber immediately prior
to use, and serial 10-fold dilutions were prepared for
evaluating median infectious doses. For isolation of
transformants, spirochetes were cultured on semi-solid
gelatin-free BSKII medium supplemented with 1.7%
dissolved agarose plus appropriate antibiotic (50 μg/ml
streptomycin or 40 μg/ml gentamicin). Escherichia coli
cloning strain TOP10F’ (Invitrogen, Inc., CA), was
grown in Luria-Bertani broth under aerobic conditions
at 37°C. Transformed E. coli were selectively cultured in
broth medium with 50 μg/ml spectinomycin.
Genetic modification of B. burgdorferi
Arp null mutants (Δarp) were constructed by exchange
of the arp open reading frame (ORF) with a mutagenic
cassette via homologous recombination. The mutagenic
cassette consisted of a streptomycin-spectinomycin re-
sistance cassette, flaB-aadA (kindly provided by D. Scott
Samuels, University of Montana, Missoula, MT), flanked
by regions of the B. burgdorferi B31-A3 plasmid lp28-1
that flanked the arp gene at both the 5′ and 3′ regions.
Single Overlap Extension PCR (SOEing) was used to join
each part of the mutagenic cassette through primers
containing overlapping homology (Table 4). First, the 5′
flanking region (258bp) was amplified using primers
ARP01 and the SOEing primer ARP02, which included
homology to the 5′ region of the flaB-aadA PCR pro-
duct. The flaB-aadA product (1199bp) was amplified
using primers ARP03 and the SOEing primer ARP04,
which included homology to the 5′ region of the 3′ re-
gion PCR product. The 3′ flanking region (1309bp) was
amplified using primers ARP05 and ARP06. Each part
was gel purified using the Qiagen Gel Extraction KitTable 4 Primers for construction of the arp mutagenic cassett












ARP10 CCAAGCGATCTTCTTCTTGTC(Qiagen Inc., Valencia, CA). SOEing was performed
using a 2μl aliquot of each part mixed with 0.5 μl (10
μM) each of primers ARP01 and ARP06 to produce a
fragment that was 2766bp in length. The resulting muta-
genic cassette was cloned into the 3.9kb commercial
vector, pCR2.1 TOPO (Invitrogen Corp., Carlsbad, CA)
to produce a 7.5 kb suicide vector, “pKH-1”. Plasmid
DNA of pKH-1 (5–10 μg) was electroporated into wild-
type B. burgdorferi using the previously described proto-
col [40]. Transformants were selected by plating onto
semi-solid BSKII medium (gelatin-free BSKII medium
supplemented with 1.7% dissolved agarose and 50 μg/ml
streptomycin). Clones that survived antibiotic selection
were analyzed by PCR to confirm allele exchange using
a combination of primers exterior and interior of the in-
tegration site (Table 4). PCR was performed to confirm
the absence of the arp gene in several potential mutants.
Plasmid profiling of Δarp mutants was performed by
PCR as previously described [28] to select mutants that
contained important plasmids, including cp9 (rev), cp26
(ospC), cp32-1 (BBP33), cp32-2/7 (BBO32), cp32-3
(ospG), cp32-6 (BBM32), cp32-8 (BBL32-34), cp32-9
(BBN32-33), lp17 (BBD12-13), lp21 (BBU06-07), lp25
(pncA), lp28-1 (vlsE), lp28-3 (BBH17), lp28-4 (non-coding
region), lp36 (BBK12), lp38 (ospD), lp54 (ospA), and lp56
(BBQ67), using previously published primers [28,41]. One
of the Δarp clones (Δarp3) that retained the same
complete set of plasmids as the wild-type isolate was used
in further experiments.
The Δarp3 clone was complemented with a whole
lp28-1 plasmid that contained the arp gene and a selec-
tion marker for gentamicin (lp28-1-G). This plasmid was
knocked in to replace the endogenous lp28-1 (where arp
was deleted), as previously published [38]. Plasmid DNA
containing lp28-1-G was purified from B. burgdorferi
B31-A3-lp28-1-G, electroporated into B31-Δarp3 spiro-
chetes, and then complemented transformants weree and verification of allelic exchange
Application
amplify arp upstream homology
CAA SOEing arp upstream homology
TAA to aadA cassette
amplify aadA cassette
AAAT SOEing arp downstream
TGGT homology to aadA cassett
TCG amplify arp dowsteam homology
G amplify arp dowsteam homology
T check integration at 5′ end
TT check integration at 3′ end
check integration within aadA
check integration within aadA
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nostic primers (Table 1) were used to identify clones that
had undergone successful plasmid exchange of lp28-1
arp::aadA with lp28-1G by confirming the presence of
the arp operon. Plasmid profiling was performed and the
complemented isolate B31-Δarp3-2.2 (Δarp3-lp28-1-G)
was used for further analysis.
Quantitative PCR
DNA was extracted from sub-inoculation site, heart
base, ventricular muscle, quadriceps muscle and right
tibiotarsus (integument removed), and samples were
subjected to real-time Q-PCR. In addition to the site of
inoculation, four additional sites were evaluated, based
upon previous studies demonstrating that they all be-
come consistently infected [22], but manifest different
patterns of inflammation. Heart base is the site where
carditis occurs, whereas cardiac ventricular muscle de-
velops minimal or no inflammation [34]. In addition, the
tibiotarsal joint typically develops arthritis, whereas the
adjacent quadriceps femoris muscle develops minimal or
no inflammation [42]. Quantification of gene copies was
based upon copy number per mg of tissue weight, as
previously described [22]. DNA was extracted from sam-
ples using the DNeasy tissue kit, according to the manu-
facturer’s instructions for tissues or insects (QIAGEN,
Valencia, CA). In addition, DNA from B. burgdorferi cul-
tured from mouse tissues was extracted for verification
of genetic status of isolates. Three oligonucleotides, two
primers and a probe, for the B. burgdorferi flaB and the
arp genes were used, as previously described [19].
Serology
Immune sera were generated in C3H mice inoculated
with 105 wild-type, Δarp3, or Δarp3 + lp28-1G spiro-
chetes at 60 days of infection. Infection was verified by
culture, and individual sera were tested by enzyme
linked immunosorbent assay (ELISA) to verify the ap-
propriate presence or absence of Arp-reactive antibody.
Three-fold dilutions (starting at 1:300) of immune sera
were titrated by ELISA for antibody to B. burgdorferi
B31 lysates and recombinant Arp, as described [11].
Samples were tested in duplicate, and each assay
included uninfected mouse serum as a negative control
and wild-type infected mouse serum as a positive
control.
Tick acquisition and transmission
Ixodes scapularis ticks were acquired from Durland Fish,
Yale University, as a single cohort of larvae from a
pathogen-free laboratory-reared colony. In order to de-
termine the ability of ticks to acquire infection, 40 larval
ticks were placed on each mouse infected with either
wild-type or Δarp3 spirochetes. Replete (fed) ticks werecollected as cohorts from each mouse and allowed to
harden and molt into nymphal ticks. Randomly selected
ticks from each mouse/tick cohort were tested for flaB
and arp by Q-PCR. Remaining nymphal ticks in each
cohort were placed on naïve C3H mice to assess the
relative ability of infected nymphal ticks to transmit
wild-type or Δarp3 spirochetes.
Statistical analysis
Multiple comparison analyses were performed using in-
dependent samples t-test or one-way analysis of vari-
ance, followed by post-hoc pair-wise comparisons
(Tukey’s HSD test) (PASW Statistics v. 18.0). Calculated
P values ≤ 0.05 were considered significant. The median
infectious dose (ID50) was calculated using the method
of Reed and Muench [43].
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